Pin-point Base Editing Platform Licensing Options

At Revvity, we believe powerful gene editing tools should be accessible at every stage of innovation, from early discovery to therapeutic development.

Whether you're exploring new biology, building a platform, or advancing toward the clinic, the Pin-point™ base editing platform is designed to grow with you.

To support this journey, we offer two streamlined licensing pathways that align with how teams actually work:

Discovery license for research and early-stage exploration
Therapeutic license for translational and clinical development

Start where you are today, scale when you're ready.

Choose the partnership model that fits your work

	Discovery License	Therapeutic License
Primary use case	Early research, target discovery, platform exploration	Therapeutic development and clinical programs
Stage alignment	Academia, biotech discovery teams, platform validation	Preclinical -> clinical -> commercial
Research use	✔	✔
Therapeutic use	✖	✔
Access to Pin-point™ system	✔	✔
Reagent supply options	✔¹	✔¹
Generate data for publication	✔	✔
Commercial development rights	✖	✔
IP rights for therapeutic use	✖	✔
Technology transfer support	✖	✔ (field specific)
Scalability to therapeutic license	✔ (seamless upgrade path)
Typical entry point	Fast, low-friction access	Structured partnnership aligned to program goals
	Contact us about a discovery license	Contact us about a therapeutic license

¹Direct supply of RUO reagents of selected configurations of the Pin-point base editing platform are possible.

Not sure where you fit?

Partners can begin with a discovery license to evaluate performance, generate key data, and de-risk their approach, then transition to a therapeutic license when advancing toward the clinic.

Additional access pathways including evaluation agreements and collaborative models are available to support different stages of engagement.

If you’re unsure, please contact our team to discuss your needs and we’d be happy to guide you.

Flexible licensing to suit your stage

We’ve designed our partnership models to be straightforward, flexible, and aligned with your scientific goals and economic stage.

Whether you need rapid access to start experiments or a clear path to therapeutic development, our team is here to support you.

Start the conversation

Connect with our team to find the right path for your program.

Pin-point™ base editing reagents are available for research use only and are not for diagnostic use or direct administration into humans or animals. The Pin-point™ base editing platform technology is available for clinical or diagnostic study and commercialization under a commercial license from Revvity.

FAQs

What's the difference between discovery and therapeutic licenses?

Discovery licenses for the Pin-point base editing platform are designed for early-stage research, including target discovery, platform evaluation, and exploratory studies.

Therapeutic licenses for the Pin-point platform support programs advancing toward clinical and commercial development, providing the rights needed for therapeutic applications.
Can I upgrade from a discovery to therapeutic license later?

Yes. Partners can begin with a discovery license to evaluate the Pin-point base editing platform and generate key data, then transition to a therapeutic license as their program advances.
Do I need a therapeutic license for preclinical research?

It depends on your intent. If your work is purely exploratory or research-focused, a discovery license is typically sufficient. If your program is being developed with the goal of advancing toward clinical or commercial use, a therapeutic license may be more appropriate. Our team can help determine the best fit based on your plans.
How quickly can I get started?

We aim to provide fast, straightforward access, especially for discovery-stage work. Timelines can vary depending on the type of agreement and scope, but our goal is to help you get started as efficiently as possible.
What reagent supply options are available?

We offer RUO reagent supply to support both discovery and therapeutic work, including access to selected configurations of the Pin-point system.

Supply approaches can be tailored based on your program needs, stage, and scale. If we can’t directly supply exactly what you need, we can connect you to a network of trusted partners who can.
What kind of support do you provide?

We tailor our support based on your goals and how you prefer to work.

This can range from straightforward access to platform use, to more hands-on support such as experimental design guidance, workflow optimization, and technology transfer for advanced programs.
Are there other ways to access the Pin-point platform besides licensing?

Yes. In addition to licensing, we offer flexible engagement options such as evaluation agreements, material transfer agreements (MTAs), and collaborative research opportunities.
Can I publish research data generated using the Pin-point platform?

Yes. We support publication of research findings generated using the Pin-point platform, helping scientific communication and dissemination.